| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.19 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |